Diagnosis and management of neurolymphomatosis

Cancer Journal (United States)

Volumn 18, Issue 5, 2012, Pages 463-468

  Baehring, Joachim M ^a   Batchelor, Tracy T ^b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

MRI; Neurolymphomatosis; NHL

Indexed keywords

BLEOMYCIN; CARBOPLATIN; CYCLOPHOSPHAMIDE; CYTARABINE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; FLUDARABINE; IMMUNOGLOBULIN; METHOTREXATE; PREDNISONE; PROCARBAZINE; RITUXIMAB; VINCRISTINE;

AUTOLOGOUS STEM CELL TRANSPLANTATION; CANCER EPIDEMIOLOGY; CANCER INVASION; CANCER LOCALIZATION; CANCER PROGNOSIS; CEREBROSPINAL FLUID CYTOLOGY; CLINICAL FEATURE; CRANIAL NERVE TUMOR; DRUG MEGADOSE; ELECTROMYOGRAM; EXTERNAL BEAM RADIOTHERAPY; HUMAN; MENINX; MULTIPLE CYCLE TREATMENT; NERVE BIOPSY; NERVE ROOT TUMOR; NEUROANATOMY; NEUROLYMPHOMATOSIS; NONHODGKIN LYMPHOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PATHOGENESIS; PERIPHERAL NERVE TUMOR; PLASMAPHERESIS; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW; TREATMENT CONTRAINDICATION; TREATMENT OUTCOME;

B-LYMPHOCYTES; CRANIAL NERVES; DIAGNOSIS, DIFFERENTIAL; HUMANS; LYMPHOMA, NON-HODGKIN; NEOPLASM INVASIVENESS; NERVOUS SYSTEM NEOPLASMS; PERIPHERAL NERVES; POLYNEUROPATHIES; POLYRADICULOPATHY;

EID: 84866890201     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/PPO.0b013e31826c5ad5     Document Type: Review

References (34)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012;62:10-29.
2. Hollender A, Kvaloy S, Lote K, et al. Prognostic factors in 140 adult patients with non-Hodgkin's lymphoma with systemic central nervous system (CNS) involvement. A single centre analysis. Eur J Cancer. 2000;36:1762-1768.
3. Pui CH, Howard SC. Current management and challenges of malignant disease in the CNS in paediatric leukaemia. Lancet Oncol. 2008; 9:257-268.
4. Jellinger K, Radiaszkiewicz T. Involvement of the central nervous system in malignant lymphomas. Virchows Arch A Pathol Anat Histol. 1976;370:345-362.
5. Currie S, Henson RA. Neurological syndromes in the reticuloses. Brain. 1971;94:307-320.
6. Gan HK, Azad A, Cher L, et al. Neurolymphomatosis: diagnosis, management, and outcomes in patients treated with rituximab. Neuro Oncol. 2010;12:212-215.
7. Baehring JM, Damek D, Martin EC, et al. Neurolymphomatosis. Neuro Oncol. 2003;5:104-115.
8. Grisariu S, Avni B, Batchelor TT, et al. Neurolymphomatosis: an International Primary CNS Lymphoma Collaborative Group report. Blood. 2010;115:5005-5011.
9. Gherardi R, Gaulard P, Prost C, et al. T-cell lymphoma revealed by a peripheral neuropathy. A report of two cases with an immunohistologic study on lymph node and nerve biopsies. Cancer. 1986;58:2710-2716.
10. Jellinger K, Kothbauer P, Weiss R, et al. Primary malignant lymphoma of the CNS and polyneuropathy in a patient with necrotizing vasculitis treated with immunosuppression. J Neurol. 1979;220:259-268.
11. Abdel Aziz KM, van Loveren HR. Primary lymphoma of Meckel's cave mimicking trigeminal schwannoma: case report. Neurosurgery. 1999; 44:859-862.
12. Borit A, Altrocchi PH. Recurrent polyneuropathy and neurolymphomatosis. Arch Neurol. 1971;24:40-49.
13. Pages M, Marty-Double C, et al. Sensory neuropathy as revealing symptom of neurolymphomatosis: report of a case with a 15-year duration. Eur Neurol. 2004;52:57-58.
14. Tajima Y, Sudo K, Matumoto A. Malignant lymphoma originating in the cauda equina mimicking the inflammatory polyradiculoneuropathy. Intern Med 2007;46:1029-1032.
15. Kuntzer T, Lobrinus JA, Janzer RC, et al. Clinicopathological and molecular biological studies in a patient with neurolymphomatosis. Muscle Nerve. 2000;23:1604-1609.
16. Hochberg FH, Baehring JM, Hochberg EP. Primary CNS lymphoma. Nat Clin Pract Neurol. 2007;3:24-35.
17. Pals ST, de Gorter DJ, Spaargaren M. Lymphoma dissemination: the other face of lymphocyte homing. Blood. 2007;110:3102-3111.
18. Bashir R, Coakham H, Hochberg F. Expression of LFA-1/ICAM-1 in CNS lymphomas: possible mechanism for lymphoma homing into the brain. J Neurooncol. 1992;12:103-110.
19. Albelda SM. Role of integrins and other cell adhesion molecules in tumor progression and metastasis. Lab Invest. 1993;68:4-17.
20. Aho R, Kalimo H, Salmi M, et al. Binding of malignant lymphoid cells to the white matter of the human central nervous system: role of different CD44 isoforms, beta 1, beta 2 and beta 7 integrins, and L-selectin. J Neuropathol Exp Neurol. 1997;56:557-568.
21. Huang K, Geoffroy JS, Singer MS, et al. A lymphocyte homing receptor (L-selectin) mediates the in vitro attachment of lymphocytes to myelinated tracts of the central nervous system. J Clin Invest. 1991;88: 1778-1783.
22. Kern WF, Spier CM, Hanneman EH, et al. Neural cell adhesion moleculeYpositive peripheral T-cell lymphoma: a rare variant with a propensity for unusual sites of involvement. Blood. 1992;79:2432-2437.
23. Misdraji J, Ino Y, Louis DN, et al. Primary lymphoma of peripheral nerve: report of four cases. Am J Surg Pathol. 2000;24:1257-1265.
24. Cheung C, Lopes D, Hung KN, et al. Neurolymphomatosis: role of positron emission tomography in diagnosis. Ann Hematol. 2012;91(8): 1313-1314.
25. Kosa SC, Peller PJ, Klein CJ. T-cell neurolymphomatosis involving cauda equina and sciatic nerves. Neurology. 2009;72:98.
26. Koyama T, O'uchi T, Matsue K. Neurolymphomatosis involving the trigeminal nerve and deep peroneal nerve in a patient with relapsed intravascular large B-cell lymphoma. Eur J Haematol. 2010;85:275-276.
27. Nishio M, Tamaki T, Ochi H, et al. Intraspinal canal neurolymphomatosis detected by FDG-PET/CT. Clin Nucl Med. 2009;34:610-612.
28. Peruzzi P, Ray-Chaudhuri A, Slone WH, et al. Reversal of neurological deficit after chemotherapy in BCL-6Ypositive neurolymphomatosis. Case report. J Neurosurg. 2009;111:247-251.
29. Shima K, Ishida C, Okino S, et al. A linear lesion along the brachial plexus on FDG-PET in neurolymphomatosis. Intern Med. 2008;47: 1159-1160.
30. Suga K, Yasuhiko K, Matsunaga N, et al. F-18 FDG PET/CT findings of a case of sacral nerve root neurolymphomatosis that occurred during chemotherapy. Clin Nucl Med. 2011;36:73-76.
31. von Falck C, Rodt T, Joerdens S, et al. F-18 2-fluoro-2-deoxy-glucose positron emission tomography/computed tomography for the detection of radicular and peripheral neurolymphomatosis: correlation with magnetic resonance imaging and ultrasound. Clin Nucl Med. 2009;34:493-495.
32. Wan MY, Ardeshna KM, Bomanji J. Neurolymphomatosis in a patient with lymphoblastic lymphoma. Br J Haematol. 2012;156:691.
33. Ye BS, Sunwoo IN, Suh BC, et al. Diffuse large B-cell lymphoma presenting as piriformis syndrome. Muscle Nerve. 2010;41:419-422.
34. Abrey LE, Batchelor TT, Ferreri AJ, et al. Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. J Clin Oncol. 2005;23:5034-5043.